Abstract:We characterized the prevalence of hematopoietic and lymphoid disease for 2923 consecutive patients presenting at 29 hospitals from August 2003 to June 2007. Diagnoses were made in our laboratory using WHO criteria based on morphologic, immunophenotypic, cytogenetic, FISH and molecular data. A total of 611 subjects (322 males/289 females) were prospectively diagnosed with MDS using WHO (2001) criteria. Update and re-evaluation of cases using MDS (2008) criteria resulted in 649 MDS cases. Using WHO (2008) criteria, refractory cytopenia with multilineage dysplasia (RCMD) accounted for 68% of total cases, refractory anemia with excess blasts (RAEB), 16.3%; refractory anemia (RA), 6.5%; refractory cytopenia with unilineage dysplasia (RCUD), 4%; and MDS-unclassifiable (MDS-U), 4.5%. Subjects were administered questionnaires and information on previous disease, work histories and exposures to potential etiologic agents such as benzene (BZ) was obtained. A total of 80/649 (13.2%) were determined to have some BZ exposure. The frequency of clonal cytogenetic abnormalities in all MDS was 30%, the most common being +8>del(20)q>del(7q)>del(5q), while the analogous frequency in BZ-exposed cases was only 24%. To further investigate the characteristics of MDS associated with BZ, we identified a subset of cases with high BZ exposure. These BZ signal cases were each matched by age and gender to two cases with no known BZ exposure. When contrasting BZ signal cases vs matched cases with no BZ exposure, we found a high odds ratio (OR) for the WHO subtype MDS-U (OR=11.1), followed by RAEB and RCUD (OR=1), RA (OR=0.7) and RCMD (OR=0.6). Multilineage dysplasia with abnormal eosinophils (MDS-Eo) was strongly associated with BZ exposure, whereas the relative risk of clonal cytogenetic abnormalities was reduced for high BZ-exposed cases (OR=0.5). These findings are strongly indicative that MDS subtypes are influenced by BZ exposure, and taken together with previous studies, the features of MDS-Eo suggest that altered immune regulation plays a major role in the pathogenesis of MDS following chronic exposure to BZ.

Chronic Exposure to Benzene Results in A Unique Form of Dysplasia

Study on Bone Marrow Dysplasia in Chronic Benzene Poisoning

Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease

Nonlinear low dose hematotoxicity of benzene; a pooled analyses of two studies among Chinese exposed workers

Multiple synchronous primary malignancies induced by benzene exposure: a case report

Integrating WHO 2001–2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): A case–case analysis of benzene exposure

Relationship between blood type distribution and occupational chronic benzene poisoning

Benzene exposure and risk of benzene poisoning in Chinese workers

The TNF-α 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene

Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers.

HIF-1α/m6A/NF-κB/CCL3 axis-mediated immunosurveillance participates in low level benzene-related erythrohematopoietic development toxicity

Hospital-Based Case-Control Study of MDS Subtypes and Benzene Exposure in Shanghai.

Aberrant Lncrna Profiles Are Associated with Chronic Benzene Poisoning and Acute Myelocytic Leukemia

[Polymorphism of XRCC1 and chromosome damage in workers occupationally exposed to benzene]

Microsomal Epoxide Hydrolase (ephx1) Polymorphisms Are Associated with Aberrant Promoter Methylation of Ercc3 and Hematotoxicity in Benzene-Exposed Workers

Peripheral blood effects in benzene-exposed workers

Benzene Exposure, Glutathione S-transferase Theta Homozygous Deletion, and Sister Chromatid Exchanges.

Epigenome-wide association studies of occupational exposure to benzene and formaldehyde

Gender differences in hematotoxicity of benzene-exposed workers, three cross-sectional studies on 218,061 subjects

Comparison of toxicity of benzene metabolite hydroquinone in hematopoietic stem cells derived from murine embryonic yolk sac and adult bone marrow.

Plasma metabolomics study reveals the critical metabolic signatures for benzene-induced hematotoxicity